VE800

· Vedanta Biosciences, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for VE800, covering 2023-08-29 to 2023-08-29. Get the full timeline:

Most recent: Clinical Trial Update: Study of VE800 and Nivolumab in Patients With Selected Types of Advanced or Metastatic Cancer [Phase 1, Phase 2]